Federal Right-to-Try Legislation — Threatening the FDA’s Public Health Mission

A bill passed by the Senate would sharply curtail the FDA’s oversight of access to investigational drugs. Although its impact would probably be limited, the motivation behind it threatens to weaken the FDA’s ability to pursue its public health mission.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2018-02, Vol.378 (8), p.695-697
Hauptverfasser:	Joffe, Steven, Lynch, Holly Fernandez
Format:	Artikel
Sprache:	eng
Schlagworte:	Bills Clinical trials Drugs FDA approval Illnesses Legislation Patients Public health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A bill passed by the Senate would sharply curtail the FDA’s oversight of access to investigational drugs. Although its impact would probably be limited, the motivation behind it threatens to weaken the FDA’s ability to pursue its public health mission.
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMp1714054